A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Newborn screening (NBS) dramatically improves outcomes in severe childhood disorders by treatment before symptom onset. In many genetic diseases, however, outcomes remain poor because NBS has lagged behind drug development. Rapid whole-genome sequencing (rWGS) is attractive for comprehensive NBS because it concomitantly examines almost all genetic diseases and is gaining acceptance for genetic disease diagnosis in ill newborns. We describe prototypic methods for scalable, parentally consented, feedback-informed NBS and diagnosis of genetic diseases by rWGS and virtual, acute management guidance (NBS-rWGS). Using established criteria and the Delphi method, we reviewed 457 genetic diseases for NBS-rWGS, retaining 388 (85%) with effective treatments. Simulated NBS-rWGS in 454,707 UK Biobank subjects with 29,865 pathogenic or likely pathogenic variants associated with 388 disorders had a true negative rate (specificity) of 99.7% following root cause analysis. In 2,208 critically ill children with suspected genetic disorders and 2,168 of their parents, simulated NBS-rWGS for 388 disorders identified 104 (87%) of 119 diagnoses previously made by rWGS and 15 findings not previously reported (NBS-rWGS negative predictive value 99.6%, true positive rate [sensitivity] 88.8%). Retrospective NBS-rWGS diagnosed 15 children with disorders that had been undetected by conventional NBS. In 43 of the 104 children, had NBS-rWGS-based interventions been started on day of life 5, the Delphi consensus was that symptoms could have been avoided completely in seven critically ill children, mostly in 21, and partially in 13. We invite groups worldwide to refine these NBS-rWGS conditions and join us to prospectively examine clinical utility and cost effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979 · cited 1×
“This cohort was significantly healthier than the UK population as a whole.(41) NBS started in the UK in 1969 and encompasses nine conditions (sickle cell disease [MIM: 603903], cystic fibrosis [MIM: 219700], congenital hypothyroidism [genetically heterogeneous], phenylketonuria [MIM: 261600], medium-chain acylCoA dehy…”
BackgroundByrska-Bishop, M., Evani, U. S., Zhao, X., Basile, A. O., Abel, H. J., Regier, A. A., Corvelo, A., Clarke, W. E., Musunuri, R., Nagulapalli, K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.08.004 · Cited by 1,094
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706 · cited 1×
“Variant pathogenicity assertions from that era are known to be frequently inflated.(57) This variant was added to the blocked list.”
BackgroundSelf-citationClark, M. M., Stark, Z., Farnaes, L., Tan, T. Y., White, S. M., Dimmock, D., & Kingsmore, S. F. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0053-8 · Cited by 619
Self-citationCurrent status of newborn screening worldwide: 2015
Therrell, B. L., Padilla, C. D., Loeber, J. G., Kneisser, I., Saadallah, A., Borrajo, G. J. C., & Adams, J. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.03.002 · Cited by 602
Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization
Farnaes, L., Hildreth, A., Sweeney, N. M., Clark, M. M., Chowdhury, S., Nahas, S., Cakici, J. A., Benson, W., Kaplan, R. H., Kronick, R., et al. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0049-4 · Cited by 445 · cited 1×
“tions at the actual age of diagnosis by rWGSwith that of treatment initiation at the counterfactual age of diagnosis by NBS-rWGS (day of life 5), as previously described.(9,16) The extent to which NBS-”
MethodSelf-citationUsing high-resolution variant frequencies to empower clinical genome interpretation
Whiffin, N., Minikel, E., Walsh, R., O’Donnell-Luria, A. H., Karczewski, K., Ing, A. Y., Barton, P. J. R., Funke, B., Cook, S. A., MacArthur, D., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.26 · Cited by 441 · cited 1×
“Pathogenicity assessments in NBS-rWGS require knowledge of frequency for each variant genotype (heterozygous, homozygous, hemizygous, or heteroplasmy fraction and frequency).(60) Because the number of disorders featured in NBS-rWGS will increase with time, it is important for NBS-rWGS to remain an open system.”
BackgroundAdvancing human genetics research and drug discovery through exome sequencing of the UK Biobank
Szustakowski, J. D., Balasubramanian, S., Kvikstad, E., Khalid, S., Bronson, P. G., Sasson, A., Wong, E., Liu, D., Wade Davis, J., Haefliger, C., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00885-0 · Cited by 401
Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases
Chen, R., Shi, L., Hakenberg, J., Naughton, B., Sklar, P., Zhang, J., Zhou, H., Tian, L., Prakash, O., Lemire, M., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3514 · Cited by 310 · cited 1×
“This agreed with two prior estimates of the frequency of severe pediatric disease alleles in large genomic datasets.(67,68) It should be noted, however, that these are not representative of global genomic diversity and evaluations were limited to nucleotide variants.”
ResultClark, M. M., Hildreth, A., Batalov, S., Ding, Y., Chowdhury, S., Watkins, K., Ellsworth, K., Camp, B., Kint, C. I., Yacoubian, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat6177 · Cited by 300
Self-citation
Cited by
Genome-scale models in human metabologenomics
Mardinoglu, A., & Palsson, B. Ø. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-024-00768-0 · Cited by 54
Metadata
- Authors
- Kingsmore, S. F., Smith, L. D., Kunard, C. M., Bainbridge, M., Batalov, S., Benson, W., Blincow, E., Caylor, S., Chambers, C., Del Angel, G., Dimmock, D. P., Ding, Y., Ellsworth, K., Feigenbaum, A., Frise, E., Green, R. C., Guidugli, L., Hall, K. P., Hansen, C., Hobbs, C. A., Kahn, S. D., Kiel, M., Van Der Kraan, L., Krilow, C., Kwon, Y. H., Madhavrao, L., Le, J., Lefebvre, S., Mardach, R., Mowrey, W. R., Oh, D., Owen, M. J., Powley, G., Scharer, G., Shelnutt, S., Tokita, M., Mehtalia, S. S., Oriol, A., Papadopoulos, S., Perry, J., Rosales, E., Sanford, E., Schwartz, S., Tran, D., Reese, M. G., Wright, M., Veeraraghavan, N., Wigby, K., Willis, M. J., Wolen, A. R., & Defay., T.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 109
- Issue
- 9
- Pages
- 1605-1619
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W4292951299
- Cited by
- 177
- References
- 13
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. https://app.cochat.ai/papers/10.1016/j.ajhg.2022.08.003
- The paper
- Kingsmore, S. F., Smith, L. D., Kunard, C. M., Bainbridge, M., Batalov, S., Benson, W., Blincow, E., Caylor, S., Chambers, C., Del Angel, G., Dimmock, D. P., Ding, Y., Ellsworth, K., Feigenbaum, A., Frise, E., Green, R. C., Guidugli, L., Hall, K. P., Hansen, C., . . . Defay., T. (2022). A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. The American Journal of Human Genetics. https://doi.org/10.1016/j.ajhg.2022.08.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.